News

Boehringer Ingelheim Acquires All ViraTherapeutics Shares to Develop Next Generation Viral-Based Immuno-Oncology Therapies

Cyclenium Pharma and Haplogen Bioscience Announce Granting of EUREKA Label and Funding to Develop Novel Therapies in Severe Viral Diseases

Tracing the footprints of a tumor: genomic “scars” allow cancer profiling

AFFiRiS Announces Encouraging Long-term Data from a Series of First-in-Human Studies Using AFFITOPE® PD01A Targeting Oligomeric Alpha-synuclein in Early Parkinson’s Disease Patients

Leonid Sazanov elected member of EMBO

Hereditary bowel cancer: mesalazine attenuates tumour formation by 50%

Arsanis Reports Business Highlights and Financial Results for First Quarter 2018

Rheumatoide arthritis: new therapeutic approach suppresses joint inflammation

Combating cancer and infectious diseases with natural milk protein

Amares and his team win the Houska-Award for SLAMseq

Secret of the Aha!-moment uncovered

New Record Results at Boehringer Ingelheim Regional Center Vienna

Boehringer Ingelheim has a very successful 2017 financial year

MedUni Vienna awards honorary doctorate to Eric Kandel

“Transcriptional wiring” of cancer genes can be resolved using Lexogen’s SLAMseq and QuantSeq technologies to facilitate drug discovery

New approach discovered for early detection of pre-eclampsia

The dark side of cichlid fish: from cannibal to caregiver

Our genes dictate who develops an allergy

Digital monitoring checks for possible malnutrition in hospital patients

Cardia arrest: heart rate in pulseless electrical activity (PEA) is a good prognostic tool